EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Conceptual Translational Bench-to-Bedside Cardiac Safety Framework for Predicting Drug-Induced QT Interval Prolongation from Molecular Structure to Clinical Data

Fianne Sips, Marc-Antonio Bisotti, Mario Torchia iD, Vincenzo Carbone iD, Nicola Gambacorta iD, Valentina Belgiovine, Fulvio Ciriaco iD, Orazio Nicolotti iD, Beatriz Trenor iD, Javier Saiz iD, Jari Hyttinen iD, Stefano Severi iD und 6 weitere

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27209312 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Fianne Sips und 17 weiteren Autor:innen. Beteiligte Einrichtung: InSilicoTrials Technologies B.V., 1017 BR Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: Phenethylamines, Verapamil, Sulfonamides, Long QT Syndrome. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Advanced Research Projects Agency for Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

QT interval prolongation is associated with an increased risk of torsades de pointes (TdP), a potentially life-threatening ventricular arrhythmia, making assessment of cardiac repolarization a critical component of drug development. This work demonstrates how integrated in silico methodologies can be used to predict and quantitatively characterize QT liability across the drug discovery and development continuum. A proof-of concept translational workflow combining molecular structure analysis, in vitro pharmacology, animal data, and clinical exposure-response modeling was evaluated using the retrospective case examples verapamil and dofetilide. Molecular structure- and pharmacology-based assessments predicted hERG channel interaction and potential QT risk for both compounds. While initial in silico analyses suggested a high QT liability for verapamil and dofetilide, mechanistic electrophysiological modeling differentiated their effects. For verapamil, concurrent calcium channel inhibition offset hERG-mediated effects, resulting in predicted reductions in action potential duration and no clinically relevant QT prolongation. In contrast, dofetilide produced concentration-dependent increases in action potential duration, consistent with its known proarrhythmic potential. Translation of nonclinical findings to humans accurately predicted the absence of clinically meaningful QT effects for verapamil and identified QT prolongation exceeding the regulatory 10 ms threshold for dofetilide at therapeutic concentrations. Drug exposure and pharmacokinetic properties could be anticipated based solely on molecular structure. This conceptual workflow demonstrates how integrated quantitative in silico approaches can support earlier identification, characterization, and communication of QT risk, enabling informed decision-making and improved development efficiency from bench to bedside.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhenethylaminesVerapamilSulfonamidesLong QT SyndromeHumansAnimalsTorsades de PointesAction PotentialsTranslational Research, BiomedicalComputer Simulation

Stichwörter der Autor:innen

QTcardiovascular safetyclinicaldrug discovery and developmentin silicoin vitroin vivomolecular structure

Substanzen

dofetilidePhenethylaminesVerapamilSulfonamides

Autor:innen und Institutionen

  • InSilicoTrials Technologies B.V., 1017 BR Amsterdam, The Netherlands.
  • InSilicoTrials Technologies S.p.A., 34123 Trieste, Italy.
  • Dipartimento di Farmacia-Scienze del Farmaco, Università degli Studi di Bari "Aldo Moro", 70125 Bari, Italy.
  • Dipartimento di Chimica, Università degli Studi di Bari "Aldo Moro", 70125 Bari, Italy.
  • Centro de Investigación e Innovación en Bioingeniería (Ci2B), Universitat Politècnica de València, 46022 Valencia, Spain.
  • Faculty of Biomedical Sciences and Engineering, Tampere University of Technology, FI-33720 Tampere, Finland.

ORCID-Profile: Mario Torchia, Vincenzo Carbone, Nicola Gambacorta, Fulvio Ciriaco, Orazio Nicolotti, Beatriz Trenor, Javier Saiz, Jari Hyttinen, Stefano Severi, Urban Fagerholm, Candice N Baker, Daniel Röshammar

Förderung

  • Advanced Research Projects Agency for Health

Zitieren

APA

Sips, F., Bisotti, M. A., Torchia, M., Carbone, V., Gambacorta, N., Belgiovine, V., Ciriaco, F., Nicolotti, O., Trenor, B., Saiz, J., Hyttinen, J., Severi, S., Fagerholm, U., Carlson, B. E., Baker, C. N., Mahoney, J. M., Röshammar, D., & CARDIOVERSE Project (2026). A Conceptual Translational Bench-to-Bedside Cardiac Safety Framework for Predicting Drug-Induced QT Interval Prolongation from Molecular Structure to Clinical Data. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27209312

Vancouver

Sips F, Bisotti MA, Torchia M, Carbone V, Gambacorta N, Belgiovine V, et al. A Conceptual Translational Bench-to-Bedside Cardiac Safety Framework for Predicting Drug-Induced QT Interval Prolongation from Molecular Structure to Clinical Data. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27209312

BibTeX
@article{Sips2026,
  author = {Sips, Fianne and Bisotti, Marc-Antonio and Torchia, Mario and Carbone, Vincenzo and Gambacorta, Nicola and Belgiovine, Valentina and Ciriaco, Fulvio and Nicolotti, Orazio and Trenor, Beatriz and Saiz, Javier and Hyttinen, Jari and Severi, Stefano and Fagerholm, Urban and Carlson, Brian E and Baker, Candice N and Mahoney, J Matthew and Röshammar, Daniel and CARDIOVERSE Project, CARDIOVERSE Project},
  title = {A Conceptual Translational Bench-to-Bedside Cardiac Safety Framework for Predicting Drug-Induced QT Interval Prolongation from Molecular Structure to Clinical Data},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27209312}
}
Kostenlos starten →